Feature Channels:

Autoimmune Diseases

Add to Favorites | Subscribe | Share

Filters:

  • (Press "esc" to clear)

Medicine

Channels:

Rheumatoid Arthritis, RA, Rheumatoid Arthritis Remission, Rheumatoid Arthritis Medication, Autoantibodies, Autoimmune Disease And Disorder, B Cells, Tumor Necrosis Factor, anti-citrullinated protein antibodies, ACPA, Methotrexate

New Assay May Lead to a Cure for Debilitating Inflammatory Joint Disease

gregg-silverman-hero-crop.jpg

Current treatments for rheumatoid arthritis relieve the inflammation that leads to joint destruction, but the immunologic defect that triggers the inflammation persists to cause relapses. Now the results of a new study suggest that clinical trials for new rheumatoid arthritis (RA) drugs should shift from their sole focus on relieving inflammation to eliminating the B cells that produce these antibodies.

Medicine

Channels:

Flu Vaccines, Medical Curriculum Tailored to Native Americans, Tackling Heart Disease, and More in the Healthcare News Source

The latest research, features and announcements in healthcare in the Healthcare News Source

Medicine

Channels:

alzheimer disease, Cognitive Decline, Aging, Latinos, Latino culture, Latino Health, Memory

New Study to Document Alzheimer’s Disease Risk Factors in Latinos

Rush University Medical Center has launched a unique, cohort study called Latino Core to learn about the aging process and risk factors for Alzheimer’s disease in older Latino adults.

Medicine

Science

Channels:

Parents Grade Themselves, Signals from Fat, Getting Teens to Exercise, and More in the Obesity News Source

Click here to go directly to Newswise's Obesity News Source

Medicine

Channels:

Fragile X Syndrome, Steven Tyler's Janie's Fund Wins Big, Untreated Water Making Our Kids Sick, and More in the Children's Health News Source

Click here for the latest research and features on Children's Health.

Medicine

Channels:

Study: Hormone Therapy May Not Protect Against Alzheimer’s Disease

The latest study on hormone therapy and Alzheimer’s disease shows no relationship between taking the drugs and whether you may develop the disease years later. Some previous studies have shown that hormone therapy may increase the risk of the disease, while others have shown that it may reduce the risk. The new study was published in the February 15, 2017, online issue of Neurology®, the medical journal of the American Academy of Neurology.

Medicine

Science

Channels:

Alzheimer's Disease, Calcium, cell energy, Mitochondria, Protein, Cell Culture, Gene, Disease Development, Pooja Jadiya, Alyssa A. Lombardi, Jonathan P. Lambert, Timothy S. Luongo, Jin Chu, Domenico Praticò, John W. Elrod, Temple University, Biophysical Society 61st Meeting, Biophysical Society

Imbalance of Calcium in a Cell's Energy Factory May Drive Alzheimer's Disease

Calcium in the mitochondria -- the energy factory of cells -- may be one of the keys to understanding and treating Alzheimer's disease and dementia. Researchers at Temple University have now identified how an imbalance of calcium ions in the mitochondria may contribute to cell death and, specifically, neurodegeneration in brain cells during Alzheimer's and dementia. The findings could eventually point to new therapies for preventing or delaying these diseases. The team will present its work during the 61st Meeting of the Biophysical Society.

Medicine

Channels:

Alzheimer's Disease, Peptides, Neurodegenerative Diseases, cell toxicity, amyloid hypothesis, Antonio De Maio, Isabel Rivera, David M. Cauvi , Nelson Arispe, University of California, San Diego, Biophysical Society 61st Meeting, Biophysical Society

New Understandings of Cell Death Show Promise for Preventing Alzheimer’s

Currently, the predominant theory behind Alzheimer’s disease is the “amyloid hypothesis,” which states that abnormally increased levels of amyloid beta (Aβ) peptides outside of brain cells produce a variety of low molecular weight Aβ aggregates that are toxic to the nervous system. These Aβ aggregates interact directly with target cells and lead to cell death. During the Biophysical Society’s meeting, being held Feb. 11-15, 2017, Antonio De Maio will present his work hunting for the specific mechanisms behind Aβ-induced toxicity to cells, or cytoxicity.

Medicine

Channels:

Parkinson's Disease, Rutgers, New Jersey, Alzheimer's Disease, Neurons, Neuroscience, Brain Disease, Neurological, Roundworm, C. Elegans, Proteins, Huntington's Disease, Science, Aging

Alzheimer’s May Be Linked to Defective Brain Cells Spreading Disease

alzheimers.jpg

Rutgers scientists say neurodegenerative diseases like Alzheimer’s and Parkinson’s may be linked to defective brain cells disposing toxic proteins that make neighboring cells sick. In a study published in Nature, Monica Driscoll, distinguished professor of molecular biology and biochemistry, School of Arts and Sciences, and her team, found that while healthy neurons should be able to sort out and rid brain cells of toxic proteins and damaged cell structures without causing problems, laboratory findings indicate that it does not always occur.

Medicine

Channels:

Huntington's Disease, Neuro-degenerative disease, Alzheimer's Disease, Parkinson's Disease

Cellular Quality Control Process Could Be Huntington’s Disease Drug Target

Duke-Health-Huntingtons.jpeg

The loss of motor function and mental acuity associated with Huntington’s disease might be treatable by restoring a cellular quality control process, which Duke Health researchers have identified as a key factor in the degenerative illness.

Medicine

Channels:

Autoimmune Disease, Lupus, Immunology, Immunobiology, autoimmune treatment

Stressed Out Interferons Reveal Potential Key to Alternative Lupus Treatment

Buskiewicz_Lab_LarnerCOMUVM_Duback_10-11-16.jpg

New research has identified a previously unknown mechanism involved in the immune response of lupus patients that could provide an alternative therapy target for the estimated 1.5 million Americans and five million-plus people worldwide suffering from this disease.

Medicine

Channels:

Geospatial Indicators on Prevention, Cocaine and Unsafe Sex, LASER ART, and More in the AIDS and HIV News Source

The latest research, features, and experts on HIV and AIDS.

Medicine

Channels:

Blood Test May Help Differentiate Parkinson’s From Similar Diseases

A simple blood test may be as accurate as a spinal fluid test when trying to determine whether symptoms are caused by Parkinson’s disease or another atypical parkinsonism disorder, according to a new study published in the February 8, 2017, online issue of Neurology®, the medical journal of the American Academy of Neurology.

Science

Channels:

Autoimmune, patient registry, Research, Diagnosis, Relapsing Polychondritis, Myasthenia Gravis, National Coalition of Autoimmune Patient Groups (NCAPG), ARNet, Autoimmune Research Network, Clinical Research, Autoimmunity, Medical Knowledge, Innovation

First Worldwide Patient-Powered Research Tool Launched by AARDA Heralds March as National Autoimmune Disease Awareness Month

AARDA-25thanniversarylogo.jpg

AARDA today unveiled the Autoimmune Research Network, known as ARNet, the world’s first fully-functioning patient registry for individuals diagnosed with one or more of the 100-plus known autoimmune diseases (ADs).

Medicine

Channels:

Vasculitis Foundation, VF, Vasculitis, Autoimmune Disease, Autoimmunity, Vasculitis Foundation Symposium, Joyce Kullman

2017 International Vasculitis Foundation Symposium Set for June 23–25 at Chicago Marriott O’Hare in Chicago, Illinois

The Vasculitis Foundation announced today that the 2017 International Vasculitis Symposium will take place from Friday, June 23 to Sunday, June 25 at the Chicago Marriott O’Hare in Chicago, Illinois.

Medicine

Channels:

Immune Cells, Mast Cells, Stress, Autoimmune Disease And Disorder, Allergies, Irritable Bowel Syndrome, Migraines, RNA, sex-specific associations , Gene Expression

Why Male Immune Cells Are From Mars and Female Cells Are From Venus

Michigan State University researchers are the first to uncover reasons why a specific type of immune cell acts very differently in females compared to males while under stress, resulting in women being more susceptible to certain diseases.

Medicine

Channels:

Alzheimer's, Alzheimer's Disease, Trem 2, myeloid cells, Neuroscience, Amyloid Plaques

Alzheimer’s Disease Researchers Solve Mystery of Beguiling Protein

Leading neuroscientists have clarified the role of a controversial immune system protein in Alzheimer’s disease, showing it has opposing effects in early and late stages of the disease. Their discovery unites previous studies that left researchers conflicted and showed the protein both exacerbates and ameliorates disease symptoms. The updated model of disease progression, published in the Journal of Neuroscience, also highlights the need to align certain therapies with disease stages when treating the 1 in 9 Americans over 65 living with Alzheimer’s.

Medicine

Channels:

Magnet, MRI, Magnetic Resonance Imaging, Neuroimaging, Alzheimer's Disease, Dementia, Medical Device, Epilepsy, Autism, Construction

Photo Gallery: USC Stevens Hall Installs the First Next-Generation 7T MRI Machine in North America

Photo Gallery: Magnet the Weight of 30 Elephants Lowered Through Roof of USC Stevens Hall for Next-Gen 7T MRI Machine

Medicine

Channels:

Acute Myeloid Leukemia, Autoimmune Disease, Myelodysplastic Syndrome

Mayo Clinic Researchers Find Association Between Therapy for Autoimmune Disease and Bone Marrow Disorders

Mayo Clinic researchers have found that azathioprine, a drug commonly used to treat autoimmune disease, may increase the risk of myeloid neoplasms. Myeloid neoplasms include a spectrum of potentially life-threatening bone marrow disorders, such as myelodysplastic syndromes and acute myeloid leukemia. The results are published in JAMA Oncology.

Medicine

Channels:

Alzheimer's, Mayo Clinic Study on Aging, Yonas Geda, Research

Mayo Clinic Researchers Find Mental Activities May Protect Against Mild Cognitive Impairment

PHOENIX – Mayo Clinic researchers have found that engaging in mentally stimulating activities, even late in life, may protect against new-onset mild cognitive impairment, which is the intermediate stage between normal cognitive aging and dementia. The study found that cognitively normal people 70 or older who engaged in computer use, craft activities, social activities and playing games had a decreased risk of developing mild cognitive impairment. The results are published in the Jan. 30 edition of JAMA Neurology.







Chat now!